This website uses cookies to provide you with a more responsive and personalized service. In order to proceed to login, however, you must formally accept our cookie policy. Please read our cookie & privacy policies for more information.

LifeScience

Roche Oncology Life Science Research Kits

Our answers. Your insights.

The Roche Oncology Life Science Research (LSR) kits are complete testing kits designed to fuel your oncology research. With broad coverage of relevant mutations, high analytical sensitivity, and a complimentary web application to analyze your data, the Roche Oncology LSR kits provide the information you need to garner real insights for oncology research.

The BRAF/NRAS Mutation Test* and KRAS Mutation Test v2* come with access to a real-time data analysis tool for automated, objective interpretation of results, while still giving you the raw data that can help in developing important insights. The BRAF/NRAS Mutation Test and KRAS Mutation Test v2 are indicated for both formalin-fixed paraffin-embedded tissue (FFPET) and plasma sample types, and run on the cobas z 480 analyzer.

 

workflow

 

 

Fast time to results and simple results reporting

Watch this example video to see the workflow of the LSR assays, highlighting the BRAF/NRAS Mutation Test, its key features and attributes, rapid turnaround time, and a step-by-step walkthrough of the simple results reporting. The workflow highlighted in this video also applies to the KRAS Mutation Test v2.

Helpful Links

LSR Checklist and Troubleshooting Guide

 

Frequently Asked Questions

No, when you use the Data Analysis tool, results are delivered direct to you. Roche does not store, view or use your data.

Interpreted data is available for 24 hours. After this period, data will need to be re-uploaded for reinterpretation.

Once you upload the raw data into the online Data Analysis tool, the results are delivered to you within a few minutes.

Turn on the cobas z 480 analyzer if it is turned off. If necessary, reboot the cobas® 4800 workstation and log into the User defined Workflow (UDF) partition on the system. Once the system has booted up, follow the appropriate assay Instructions for Use for more information on the Run Setup.

Roche recommends the cobas® DNA Sample Preparation Kit, however, the Roche Oncology LSRs are robust enough to work with a variety of DNA sample preparation methods. Per the Instructions for Use, the test requires 150ng of genomic DNA. Please see the appropriate assay Instructions for Use for more detailed information regarding DNA preparation.

The Roche Oncology LSRs come with the same quality of support you get with other Roche assays. Roche representatives are available for troubleshooting and training as needed. For specific questions and concerns, please contact your local Roche representative.

The Data Analysis tool is best viewed in Google Chrome 3 or above, Mozilla Firefox 3.5 or above, and Microsoft Internet Explorer 7 or above.

*For Life Science Research Use Only

LSR Data Analysis Tool

The Life Science Research (LSR) Data Analysis tool gives researchers access to Roche Diagnostics' unique testing algorithms to automatically interpret data generated by the BRAF/NRAS Mutation Test* and KRAS Mutation Test v2* LSR kits. This tool is a free service that provides automated, objective interpretation of results, while still providing the raw data that can help in developing important insights. Rather than having to analyze all individual data points manually, researchers can have data files analyzed and results generated within minutes.

 

Key features and benefits

  • Results are generated in both .pdf and .csv formats
  • Automatically interprets data from both BRAF/NRAS and KRAS v2 LSR kits
  • Software service and reporting is complimentary for registered LSR users
  • Results available in minutes
This application is supported only on laptops/desktops. Please access the webpage in desktop/laptop.

 

Fast time to results

Watch this example video to see the workflow of the LSR assays, highlighting the BRAF/NRAS Mutation Test and its key features and attributes. The workflow highlighted in this video also applies to the KRAS Mutation Test v2.

 

 

Workflow

workflow

Helpful links

Frequently Asked Questions

No, when you use the Data Analysis tool, results are delivered direct to you. Roche does not store, view or use your data.

Interpreted data is available for 24 hours. After this period, data will need to be re-uploaded for reinterpretation.

Once you upload the raw data into the online Data Analysis tool, the results are delivered to you within a few minutes.

References

*For Life Science Research Use Only

 

BRAF/NRAS Mutation Test (LSR)

The BRAF/NRAS Mutation Test* is an allele-specific, real-time polymerase chain reaction (PCR) test for the qualitative detection and identification of exons 11 and 15 mutations in the proto-oncogene B-Raf (BRAF) gene, and exons 2, 3 and 4 mutations in the neuroblastoma RAS (NRAS) viral oncogenes.

The BRAF/NRAS Mutation Test can be used with both formalin-fixed paraffin-embedded tissue (FFPET) and plasma sample types. Each test comes with liquid, ready-to-use reagents for increased laboratory efficiency.

 

Key features and benefits1

  • Results from a single, 5µm FFPET section of tissue or 2mL plasma
  • 100% repeatability over multiple specimens, operators, instruments, and days
  • Sensitivity ≥ 5% mutant alleles in a wild-type in DNA isolated from FFPET samples
  • Sensitivity as low as 100 copies/mL in DNA isolated from plasma samples
  • > 98% overall concordance to NGS for FFPET and plasma

 

Product highlights

  • Broad detection of BRAF and NRAS mutations within an 8-hour laboratory shift
  • Ability to run FFPET and plasma sample types in the same test run
  • Ability to combine test run with KRAS v2 (LSR) for expanded mutation testing
  • Complimentary access to the LSR Data Analysis Tool



Workflow

workflow
Coverage of the BRAF/NRAS Mutation Test (LSR):
NRAS COSMIC v.80   SKIN COLON
Freq of Reports LSR Coverage Freq of Reports LSR Coverage
exon 2 13.0% 11.8% 42.9% 42.4%
exon 3 86.6% 84.4% 55.8% 54.7%
exon 4 <1%
 <1% <1% <1%
TOTAL 99.5% 96.3% 98.7% 97.1%
BRAF COSMIC v.80   SKIN COLON
Freq of Reports LSR Coverage Freq of Reports LSR Coverage
exon 11 <1% <1% <1% <1%
exon 15 98.7% 96.3% 99.4% 98.4%
TOTAL 99.0% 96.5% 99.6% 98.5%
Porudct Description Quantity Material Number
BRAF/NRAS Mutation Test (LSR) 24 07659962001
cobas® 4800 UDF v2.0.0 CD 1 07540922001
cobas® 4800 Microwell Plate and Sealing Foil 50 05232724001

References

1. BRAF/NRAS Mutation Test package insert

*For Life Science Research Use Only

KRAS Mutation Test v2 (LSR)

The KRAS Mutation Test v2* is an allele-specific, real-time polymerase chain reaction (PCR) test for the qualitative detection and identification of 28 mutations in exons 2, 3 and 4 in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) gene. The KRAS Mutation Test v2 can be used with both formalin-fixed paraffin-embedded tissue (FFPET) and plasma sample types. Each test comes with liquid, ready-to-use reagents for increased laboratory efficiency.

 

Key features and benefits1

  • Results from a single, 5µm FFPET section of tissue or 2mL plasma
  • 100% repeatability over multiple specimens, operators, instruments and days
  • Sensitivity =1% mutant alleles in a wild-type in DNA isolated from FFPET samples
  • Sensitivity of =100 copies/mL in DNA isolated from plasma samples
  • > 99% overall concordance to NGS for FFPET and 92% overall concordance to NGS for

 

Product highlights

  • Broad detection of KRAS mutations within an 8-hour laboratory shift
  • Ability to run FFPET and plasma sample types in the same test run
  • Ability to combine test run with BRAF/NRAS (LSR) for expanded mutation testing
  • KRAS v2 FFPET reports will display KRAS G12C separately
  • Complimentary access to the LSR Data Analysis Tool

 





Workflow

workflow
Coverage of the KRAS Mutation Test v2 (LSR):
KRAS COSMIC v.81   COLON LUNG PANCREAS
Freq of Reports LSR Coverage Freq of Reports LSR Coverage Freq of Reports LSR Coverage
exon 2 98.3% 97.7% 98.7% 97.7% 98.8% 98.3%
exon 3 1.0% 0.9% 1.2% 1.1% 1.1% 1.0%
exon 4 0.7% 0.5% 0.06% 0.04% 0.08% 0.04%
all others** 0.01% 0.0% 0.04% 0.0% 0.0% 0.0%
TOTAL 100.0% 99.1% 100.0% 98.8% 100.0% 99.3%
Product Description Quantity Material Number
KRAS Mutation Test v2 (LSR) 24 07989270001
cobas® 4800 UDF v2.0.0 CD 1 07540922001
cobas® 4800 Microwell Plate and Sealing Foil 50 05232724001

References

1. KRAS Mutation Test v2 package insert

*For Life Science Research Use Only

** Mutations outside exon 2, 3 and 4.